LIAISON MeMed BV, LIAISON MeMed BV Control Set— 510(k) K213936

Name: FDA 510(k) clearance K213936
Creator: U.S. Food and Drug Administration
Published: 2022-07-14

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K213936 for LIAISON MeMed BV, LIAISON MeMed BV Control Set, Substantially Equivalent on 2022-07-14. Applicant: DiaSorin, Inc.. Device class: 2.

Clearance details

Applicant: DiaSorin, Inc.
Product code: Code QPS
Device class: Class 2
Regulation: 21 CFR 866.3215
Advisory panel: Microbiology
Date received: 2021-12-16
Decision date: 2022-07-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code QPS

view all

K230944 — MeMed BV2023-06-30
K222332 — MeMed BV2023-03-23
K210254 — MeMed BV2021-09-01

More clearances from DiaSorin, Inc.

view all

K260770 — LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX2026-06-04
DEN250032 — LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261)2025-12-23
K231214 — LIAISON VZV IgG HT, LIAISON Control VZV IgG HT2023-10-27
K223403 — LIAISON Anti-HAV; LIAISON XS2022-12-09
K213858 — LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus2022-07-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.